- $1.45bn
- $1.39bn
- $1.11bn
- 87
- 57
- 63
- 79
Annual cashflow statement for Omnicell, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | 32.2 | 77.8 | 5.65 | -20.4 | 12.5 |
Depreciation | |||||
Deferred Taxes | |||||
Non-Cash Items | 51.3 | 75.6 | 83.7 | 73.3 | 42 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | 37.3 | -3.34 | -73.5 | 43.7 | 58.3 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Prepaid Expenses | |||||
Change in Other Assets | |||||
Change in Accounts Payable | |||||
Change in Accrued Expenses | |||||
Change in Other Liabilities | |||||
Cash from Operating Activities | 186 | 232 | 77.8 | 181 | 188 |
Capital Expenditures | -54.9 | -58.3 | -60.7 | -55 | -52.8 |
Purchase of Fixed Assets | |||||
Software Development Costs | |||||
Other Investing Cash Flow Items | -225 | -354 | 2.07 | 0 | 0 |
Acquisition of Business | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -280 | -412 | -58.7 | -55 | -52.8 |
Financing Cash Flow Items | -5.3 | -20 | -8.93 | 3.17 | -9.15 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 456 | 47.4 | -21 | 23.4 | -236 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 363 | -134 | -2.79 | 148 | -102 |